IP Library Granted Patent US 10,030,106
Granted Patent B2
US 10,030,106 · App. 14/891,148 · Granted Jul 24, 2018

Method and catalyst system for preparing polymers and block copolymers

Inventors: Charlotte Katherine Williams (London, GB); Charles Romain (London, GB); Michael Kember (London, GB)
Assignee: Imperial Innovations Limited
C08G81/00C08G63/08C08G63/42C08G63/64C08G63/82C08G63/823C08G63/83
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,106
App. No.
14/891,148
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention provides methods for producing block copolymers, either by the sequential addition of monomers, or using a “one-pot” method. The invention also relates to novel methods for producing polyesters by ring opening lactides and/or lactones and by copolymerizing anhydrides and epoxides.

Claims (55)

1. A method for producing a block copolymer, using a single catalytic system, wherein the single catalytic system comprises a catalyst of formula (IA):

wherein

R 1 and R 2 are independently hydrogen, halide, a nitro group, a nitrile group, an imine, an amine, an ether group, a silyl ether group, a thioether group, a sulfoxide group, a sulfinate group, an acetylide group, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted haloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alicyclic, or optionally substituted heteroalicyclic;

R 3 is optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene, optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, optionally substituted arylene, optionally substituted heteroarylene, or optionally substituted cycloalkylene, wherein each alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, and heteroalkynylene may optionally be interrupted by aryl, heteroaryl, alicyclic, or heteroalicyclic;

R 4 is H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl, or optionally substituted alkylaryl;

R 5 is H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl, or optionally substituted alkylaryl;

E 1 is C, E 2 is O, S or NH; or E 1 is N and E 2 is O;

Z is absent or selected from -E-, -EX(E)-, or EX(E)E-;

X is C or S;

Each E is independently selected from O, S or NR Z , wherein R Z is H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylaryl, or optionally substituted alkylheteroaryl;

R is hydrogen, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylaryl, optionally substituted alkylheteroaryl, silyl, or a polymer; and when Z is absent, R may additionally be selected from halide, phosphinate, azide, or nitro;

each G is independently absent or a neutral or anionic donor ligand which is a Lewis base; and

M is Zn(II), Cr(II), Co(II), Mn(II), Mg(II), Fe(II), Ti(II), Cr(III)-Z—R, Co(III)-Z—R, Mn (III)-Z—R, Fe(III)-Z—R, Ca(II), Ge(II), Al(III)-Z—R, Ti(III)-Z—R, V(III)-Z—R, Ge(IV)-(—Z—R) 2 , or Ti(IV)-(—Z—R) 2 ;

the method comprising the steps of:

a) forming a first block by polymerising a first monomer or combination of monomers selected from the groups (i) to (iii):

Group (i): a lactide and/or a lactone,

Group (ii): an epoxide and an anhydride, or

Group (iii): an epoxide and carbon dioxide,

b) optionally contacting the catalyst of formula (IA) with a compound [Y] which is capable of converting the group —Z—R, wherein Z is absent or a group selected from -E-X(E)- or -E-X(E)E-, to a group —Z—R wherein Z is -E-;

c) forming a second block by polymerising a second monomer or combination of monomers selected from a different group (i) to (iii) to that selected for the first monomer or combination of monomers:

Group (i): a lactide and/or a lactone,

Group (ii): an epoxide and an anhydride, or

Group (iii): an epoxide and carbon dioxide,

 wherein when the first monomer or combination of monomers is Group (i), Z is -E-; and

 wherein when the first monomer or combination of monomers is group (ii) or Group (iii)-, and the second monomer or combination of monomers is Group (i), step b) is performed after step a).

2. The method according to claim 1 , wherein the first monomer or combination of monomers is Group (i), and Z—R is -E-R, the second monomer or combination of monomers is Group (ii) or Group (iii), and the second monomer or combination of monomers is added to the reaction after step a) has been performed.

3. The method according to claim 1 , wherein the first monomer or combination of monomers is Group (ii) or Group (iii), the second monomer or combination of monomers is Group (i), and step b) is performed after step a) and before step c).

4. The method according to claim 3 , wherein the second monomer or combination of monomers is added to the reaction with the first monomer or combination of monomers, or after step a) has been performed.

5. The method according to claim 1 , wherein the compound [Y] is a compound having a three, four or five membered saturated ring and at least one heteroatom selected from O, S or N.

6. The method according to claim 1 , wherein each E is O.

7. The method according to claim 1 , wherein M is Zn or Mg.

8. The method according to claim 1 , wherein the catalyst is selected from:

[L 1 Mg 2 Cl 2 (methylimidazole)],

[L 1 Mg 2 Cl 2 (dimethylaminopyridine)],

[L 1 Mg 2 Br 2 (dimethylaminopyridine)],

[L 1 Zn 2 (F 3 CCOO) 2 ],

[L 1 Zn 2 (OOCC(CH 3 ) 3 ) 2 ],

[L 1 Zn 2 (OC 6 H 5 ) 2 ],

[L 1 Fe 2 Cl 4 ],

[L 1 Co 2 (OAc) 3 ],

[L 1 Zn 2 (adamantyl carbonate) 2 ],

[L 1 Zn 2 (pentafluorobenzoate) 2 ],

[L 1 Zn 2 (diphenylphosphinate) 2 ],

[L 1 Zn 2 (bis(4-methoxy)phenyl phosphinate) 2 ],

[L 1 Zn 2 (hexanoate) 2 ],

[L 1 Zn 2 (octanoate) 2 ],

[L 1 Zn 2 (dodecanoate) 2 ],

[L 1 Mg 2 (F 3 CCOO) 2 ],

[L 1 Mg 2 Br 2 ],

[L 1 Zn 2 (C 6 F 5 ) 2 ],

[L 1 Zn 2 (C 6 H 5 ) 2 ], and

[L 1 Zn 2 (OiPr) 2 ].

9. The method according to claim 1 , wherein the catalyst system comprises a chain transfer agent.

10. The method of claim 6 , wherein the compound [Y] is an epoxide, an aziridine, an episulfide, an oxetane, a thietane, an azetidine, a saturated furan, a saturated thiophene, a pyrrolidine, or a saturated four-membered carbon ring where two adjacent carbon atoms are replaced by —Y—C(Y)—, wherein each Y is independently selected from O, S or NR Y , and wherein R Y is H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylaryl, or optionally substituted alkylheteroaryl.

11. The method of claim 5 , wherein the compound [Y] is an epoxide.

Assignments (2)
CHANGE OF NAME Recorded Sep 17, 2019
From: IMPERIAL INNOVATIONS LIMITED
To: IP2IPO INNOVATIONS LIMITED
Reel/Frame 050403/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2016
From: WILLIAMS, CHARLOTTE KATHERINE; ROMAIN, CHARLES; KEMBER, MICHAEL
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 038139/0685 →
Priority Claims (1)
GB 1308978.4 · May 17, 2013 · national
Continuity (1)
Related Publication 20160108181A1 · Apr 21, 2016